亚低温技术在心脏骤停后综合征脑保护治疗中的应用  

Application of mild hypothermia in post-cardiac arrest syndrome brain protection

作　　者：秦克秀[1] 王天辰[2] 张泓[1] 

机构地区：[1]安徽医科大学第一附属医院急诊科,安徽合肥230022 [2]山东大学医学院,山东济南250012

出　　处：《中国医药科学》2013年第8期52-54,共3页China Medicine And Pharmacy

摘　　要：心脏骤停患者自主循环恢复后易产生广泛的组织器官损伤,亚低温(32～34℃)治疗能改善预后和使患者获益。临床上可以选用降温毯、冷液体快速静脉输注、自粘型水凝胶包被、血管内冷却降温、冰敷冰帽等多种措施使体温降低。一般认为在心肺复苏后0.5～0.6h内开始降温是一个合适的"亚低温治疗时间窗",低温时间l2～24h,然后缓慢(0.25～0.5℃/h)复温到36.5℃。寒战、肺部感染、低血压、心律失常、血小板减少是低温治疗过程中常见的不良反应。The cardiac arrest patients after the return of spontaneous circulation caused organ damage extensive, mild hypothermia （32 -34 ℃ ） treatment could improve the prognosis and bring many benefit to the patients. Cooling blankets, cold liquid rapid intravenous infusion, self-adhesive hydrogel coated intravascular cool-down, ice cap and other measures are used to lower the body temperature. It was generally considered that starting to lower the temperature of the patients within 0.5-0.6 h after cardiopulmonary resuscitation was a suitable ＂mild hypothermia therapy time window＂, maintaining the low temperature 12 to 24 hours, and then rewarming slowly （0.25-0.5 ℃/h） to the temperature of 36.5 ℃ . Chills, lung infection, hypotension, arrhythmias, thrombocytopenia were the common adverse reactions during the process of mild therapeutic hypothermia.

关 键 词：心脏骤停后综合征 亚低温技术 应用 不良反应 

分 类 号：R541.78[医药卫生—心血管疾病]